Daksh Chemoleums Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 K
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 0.30 M
- Revenue Growth 27.77%
- Profit Growth 45.67%
- Ebitda 583.58%
- Net Worth -8.26%
- Total Assets 135.76%
About Daksh Chemoleums
Daksh Chemoleums Private Limited (DCPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 February 2015 (Nine years and 11 months 21 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 K .
The company has closed loans amounting to ₹0.30 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shalini Dixit and Dheeraj Dixit serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2015PTC069154
-
Company No.
069154
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Feb 2015
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Daksh Chemoleums?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shalini Dixit
|
Director | 23-Feb-2015 | Current |
|
Dheeraj Dixit
|
Director | 23-Feb-2015 | Current |
Financial Performance of Daksh Chemoleums.
Daksh Chemoleums Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 27.77% increase. The company also saw a substantial improvement in profitability, with a 45.67% increase in profit. The company's net worth dipped by a decrease of 8.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daksh Chemoleums?
In 2017, Daksh Chemoleums had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹0.30 M
Charges Breakdown by Lending Institutions
- Others : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2017 | Others | ₹0.30 M | Satisfied |
How Many Employees Work at Daksh Chemoleums?
Unlock and access historical data on people associated with Daksh Chemoleums, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daksh Chemoleums, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daksh Chemoleums's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.